Tetracosactide
- Generic Name
- Tetracosactide
- Brand Names
- Cortrosyn, Synacthen
- Drug Type
- Small Molecule
- Chemical Formula
- C136H210N40O31S
- CAS Number
- 16960-16-0
- Unique Ingredient Identifier
- 72YY86EA29
- Background
Tetracosactide (also known as Cosyntropin) is a synthetic peptide that is identical to the 24-amino acid segment (sequence: SYSMEHFRWGKPVGKKRRPVKVYP) at the N-terminal of adrenocorticotropic hormone. ACTH (1-24), a segment similar in all species, contains the biological activity that stimulates production of corticosteroids in the adrenal cortex. Tetracosact...
- Indication
For use as a diagnostic agent in the screening of patients presumed to have adrenocortical insufficiency.
- Associated Conditions
- Acute Gouty Arthritis, Acute Rheumatic Fever, Adrenal Insufficiency, Ankylosing Spondylitis (AS), Bell's Palsy, Choroiditis, Conjunctivitis, Dermatomyositis (DM), Iritis, Keratitis, Lupus Erythematosus, Multiple sclerosis exacerbation, Nephrotic Syndrome, Ophthalmia, Sympathetic, Optic Neuritis, Panhypopituitarism, Pemphigus, Periarteritis nodosa, Psoriatic Arthritis, Rheumatoid Arthritis, Scleroderma, Still's Disease, Ulcerative Colitis, Uveitis, Acquired hemolytic jaundice, Exfoliative erythroderma
- Associated Therapies
- -
Study of the Approximate Entropy of Adrenocorticotropic Hormone and Cortisol Secretion in Patients With Head Injury
- Conditions
- First Posted Date
- 2000-09-12
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- National Center for Research Resources (NCRR)
- Target Recruit Count
- 32
- Registration Number
- NCT00006270
- Locations
- 🇺🇸
Transitional Learning Community, Galveston, Texas, United States
🇺🇸University of Texas Medical Branch, Galveston, Texas, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath